Comparison of pregnancy outcomes in Dutch kidney recipients with and without calcineurin inhibitor exposure: a retrospective study

Lisanne M. Koenjer*, Jildau R. Meinderts, Olivier W. H. van der Heijden, Titia Lely, Margriet F. C. de Jong, Renate G. van der Molen, Henk W. van Hamersvelt

*Bijbehorende auteur voor dit werk

OnderzoeksoutputAcademicpeer review

13 Downloads (Pure)

Samenvatting

Within pregnancies occurring between 1986 and 2017 in Dutch kidney transplant recipients (KTR), we retrospectively compared short-term maternal and foetal outcomes between patients on calcineurin inhibitor (CNI) based (CNI+) and CNI-free immunosuppression (CNI-). We identified 129 CNI+ and 125 CNI- pregnancies in 177 KTR. Demographics differed with CNI+ having higher body mass index (P = 0.045), shorter transplant-pregnancy interval (P < 0.01), later year of transplantation and -pregnancy (P < 0.01). Serum creatinine levels were numerically higher in CNI+ in all study phases, but only reached statistical significance in third trimester (127 vs. 105 mu m; P < 0.01), where the percentual changes from preconceptional level also differed (+3.1% vs. -2.2% in CNI-; P = 0.05). Postpartum both groups showed 11-12% serum creatinine rise from preconceptional level. Incidence of low birth weight (LBW) tended to be higher in CNI+ (52% vs. 46%; P = 0.07). Both groups showed equal high rates of preterm delivery. Using CNIs during pregnancy lead to a rise in creatinine in the third trimester but does not negatively influence the course of graft function in the first year postpartum or direct foetal outcomes. High rates of preterm delivery and LBW in KTR, irrespective of CNI use, classify all pregnancies as high risk.

Originele taal-2English
Pagina's (van-tot)2669-2679
Aantal pagina's11
TijdschriftTransplant International
Volume34
Nummer van het tijdschrift12
Vroegere onlinedatum19-nov-2021
DOI's
StatusPublished - dec-2021

Citeer dit